Recruiting Fabry Disease Studies in Little Rock
About Fabry Disease Clinical Trials in Little Rock
Fabry disease is a rare genetic disorder caused by deficiency of the enzyme alpha-galactosidase A, leading to accumulation of a fatty substance in cells. It can affect the heart, kidneys, and nervous system. Treatment includes enzyme replacement therapy and chaperone therapy.
There are currently 2 fabry disease clinical trials recruiting participants in Little Rock, AR. These studies are seeking a combined 9,450 participants. Research is being sponsored by Genzyme, a Sanofi Company, Amicus Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.
Fabry Disease Clinical Trials in Little Rock — FAQ
Are there fabry disease clinical trials in Little Rock?
Yes, there are 2 fabry disease clinical trials currently recruiting in Little Rock, AR. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Little Rock?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Little Rock research site will contact you about next steps.
Are clinical trials in Little Rock free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Little Rock studies also compensate for your time and travel.
What fabry disease treatments are being tested?
The 2 active trials in Little Rock are testing new therapies including novel drugs, biologics, and treatment approaches for fabry disease.
Data updated October 12, 2026 from ClinicalTrials.gov